Cancer: Hematogenous dissemination of glioblastoma multiforme

Science Translational Medicine

Volumn 6, Issue 247, 2014, Pages

  Müller, Carolin ^a   Holtschmidt, Johannes ^a,b   Auer, Martina ^c   Heitzer, Ellen ^c   Lamszus, Katrin ^a   Schulte, Alexander ^a   Matschke, Jakob ^a   Langer Freitag, Sabine ^d   Gasch, Christin ^a   Stoupiec, Malgorzata ^a   Mauermann, Oliver ^a   Peine, Sven ^a   Glatzel, Markus ^a   Speicher, Michael R ^c   Geigl, Jochen B ^c   Westphal, Manfred ^a   Pantel, Klaus ^a   Riethdorf, Sabine ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b KLINIKEN ESSEN MITTE   (Germany)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; EGFR PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; TUMOR MARKER;

ADULT; ARTICLE; BLOOD SAMPLING; CANCER CELL; CHROMOSOME 10; CHROMOSOME 7; CHROMOSOME ABERRATION; CIRCULATING TUMOR CELL; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DISEASE ASSOCIATION; EGFR GENE; FEMALE; GAIN OF FUNCTION MUTATION; GENE; GENE AMPLIFICATION; GLIOBLASTOMA; GLIOBLASTOMA CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; LOSS OF FUNCTION MUTATION; MAJOR CLINICAL STUDY; MALE; ORGAN TRANSPLANTATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR INVASION; BRAIN NEOPLASMS; CASE CONTROL STUDY; CHEMISTRY; FLUORESCENCE IN SITU HYBRIDIZATION; GENETICS; MIDDLE AGED; PATHOLOGY; SECONDARY; TUMOR CELL LINE; TUMOR EMBOLISM;

BRAIN NEOPLASMS; CASE-CONTROL STUDIES; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 10; CHROMOSOMES, HUMAN, PAIR 7; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; GENE AMPLIFICATION; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; NEOPLASTIC CELLS, CIRCULATING; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR MARKERS, BIOLOGICAL;

EID: 84908464028     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3009095     Document Type: Article

References (59)

1. S. A. Grossman, X. Ye, S. Piantadosi, S. Desideri, L. B. Nabors, M. Rosenfeld, J. Fisher; NABTT CNS Consortium, Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United States. Clin. Cancer Res. 16, 2443-2449 (2010).
2. R. Stupp, W. P. Mason, M. J. van den Bent, M. Weller, B. Fisher, M. J. Taphoorn, K. Belanger, A. A. Brandes, C. Marosi, U. Bogdahn, J. Curschmann, R. C. Janzer, S. K. Ludwin, T. Gorlia, A. Allgeier, D. Lacombe, J. G. Cairncross, E. Eisenhauer, R. O. Mirimanoff; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups, National Cancer Institute of Canada Clinical Trials Group, Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 352, 987-996 (2005). (Pubitemid 40349501)
3. E. Fonkem, M. Lun, E. T. Wong, Rare phenomenon of extracranial metastasis of glioblastoma. J. Clin. Oncol. 29, 4594-4595 (2011).
4. G. Kalokhe, S. A. Grimm, J. P. Chandler, I. Helenowski, A. Rademaker, J. J. Raizer, Metastatic glioblastoma: Case presentations and a review of the literature. J. Neurooncol. 107, 21-27 (2012).
5. B. Pasquier, D. Pasquier, A. N'Golet, M. H. Panh, P. Couderc, Extraneural metastases of astrocytomas and glioblastomas: Clinicopathological study of two cases and review of literature. Cancer 45, 112-125 (1980). (Pubitemid 10214965)
6. B. H. Liwnicz, L. J. Rubinstein, The pathways of extraneural spread in metastasizing gliomas: A report of three cases and critical review of the literature. Hum. Pathol. 10, 453-467 (1979). (Pubitemid 9209187)
7. B. Pasquier, D. Pasquier, A. Lachard, A. N'Golet, M. H. Panh, P. Couderc, Extraneural metastasis of central nervous system tumours (author's transl). Bull. Cancer 66, 25-28 (1979). (Pubitemid 9116437)
8. F. Pansera, E. Pansera, An explanation for the rarity of extraaxial metastases in brain tumors. Med. Hypotheses 39, 88-89 (1992).
9. N. Sanai, Y. Polley, W. McDermott, A. T. Parsa, M. S. Berger, An extent of resection threshold for newly diagnosed glioblastomas. J. Neurosurg. 115, 3-8 (2011).
10. C. Böhm, H. Wassmann, W. Paulus, No evidence of tumour cells in blood of patients with glioma. Mol. Pathol. 56, 187-189 (2003). (Pubitemid 36724232)
11. C. A. Del Vecchio, C. P. Giacomini, H. Vogel, K. C. Jensen, T. Florio, A. Merlo, J. R. Pollack, A. J. Wong, EGFRvIII gene rearrangement is an early event in glioblastoma tumorigenesis and expression defines a hierarchy modulated by epigenetic mechanisms. Oncogene 32, 2670-2681 (2013).
12. R. G. Verhaak, K. A. Hoadley, E. Purdom, V. Wang, Y. Qi, M. D. Wilkerson, C. R. Miller, L. Ding, T. Golub, J. P. Mesirov, G. Alexe, M. Lawrence, M. O'Kelly, P. Tamayo, B. A. Weir, S. Gabriel, W. Winckler, S. Gupta, L. Jakkula, H. S. Feiler, J. G. Hodgson, C. D. James, J. N. Sarkaria, C. Brennan, A. Kahn, P. T. Spellman, R. K. Wilson, T. P. Speed, J. W. Gray, M. Meyerson, G. Getz, C. M. Perou, D. N. Hayes; Cancer Genome Atlas Research Network, Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17, 98-110 (2010).
13. S. Mazzoleni, L. S. Politi, M. Pala, M. Cominelli, A. Franzin, L. Sergi Sergi, A. Falini, M. De Palma, A. Bulfone, P. L. Poliani, R. Galli, Epidermal growth factor receptor expression identifies functionally and molecularly distinct tumor-initiating cells in human glioblastoma multiforme and is required for gliomagenesis. Cancer Res. 70, 7500-7513 (2010).
14. C. Alix-Panabières, H. Schwarzenbach, K. Pantel, Circulating tumor cells and circulating tumor DNA. Annu. Rev. Med. 63, 199-215 (2012).
15. J. Middeldorp, E. M. Hol, GFAP in health and disease. Prog. Neurobiol. 93, 421-443 (2011).
16. L. F. Eng, R. S. Ghirnikar, Y. L. Lee, Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). Neurochem. Res. 25, 1439-1451 (2000).
17. C. S. Jung, C. Foerch, A. Schänzer, A. Heck, K. H. Plate, V. Seifert, H. Steinmetz, A. Raabe, M. Sitzer, Serum GFAP is a diagnostic marker for glioblastoma multiforme. Brain 130, 3336-3341 (2007). (Pubitemid 350209077)
18. L. Danielyan, G. Tolstonog, P. Traub, J. Salvetter, C. H. Gleiter, D. Reisig, R. Gebhardt, G. H. Buniatian, Colocalization of glial fibrillary acidic protein, metallothionein, and MHC II in human, rat, NOD/SCID, and nude mouse skin keratinocytes and fibroblasts. J. Invest. Dermatol. 127, 555-563 (2007).
19. M. C. Lim, G. Maubach, L. Zhuo, Glial fibrillary acidic protein splice variants in hepatic stellate cells-Expression and regulation. Mol. Cells 25, 376-384 (2008).
20. E. Heitzer, M. Auer, C. Gasch, M. Pichler, P. Ulz, E. M. Hoffmann, S. Lax, J. Waldispuehl-Geigl, O. Mauermann, C. Lackner, G. Höfler, F. Eisner, H. Sill, H. Samonigg, K. Pantel, S. Riethdorf, T. Bauernhofer, J. B. Geigl, M. R. Speicher, Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing. Cancer Res. 73, 2965-2975 (2013).
21. S. Gröschel, R. F. Schlenk, J. Engelmann, V. Rockova, V. Teleanu, M. W. Kühn, K. Eiwen, C. Erpelinck, M. Havermans, M. Lübbert, U. Germing, I. G. Schmidt-Wolf, H. B. Beverloo, G. J. Schuurhuis, G. J. Ossenkoppele, B. Schlegelberger, L. F. Verdonck, E. Vellenga, G. Verhoef, P. Vandenberghe, T. Pabst, M. Bargetzi, J. Krauter, A. Ganser, P. J. Valk, B. Löwenberg, K. Döhner, H. Döhner, R. Delwel, Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: A study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group. J. Clin. Oncol. 31, 95-103 (2013).
22. P. Dutta, T. Bui, K. A. Bauckman, K. Keyomarsi, G. B. Mills, M. Nanjundan, EVI1 splice variants modulate functional responses in ovarian cancer cells. Mol. Oncol. 7, 647-668 (2013).
23. X. Deng, Y. Cao, Y. Liu, F. Li, K. Sambandam, S. Rajaraman, A. S. Perkins, A. P. Fields, M. R. Hellmich, C. M. Townsend Jr., E. A. Thompson, T. C. Ko, Overexpression of Evi-1 oncoprotein represses TGF-b signaling in colorectal cancer. Mol. Carcinog. 52, 255-264 (2013).
24. J. S. Gao, Y. Zhang, X. Tang, L. D. Tucker, P. M. Tarwater, P. J. Quesenberry, I. Rigoutsos, B. Ramratnam, The Evi1, microRNA-143, K-Ras axis in colon cancer. FEBS Lett. 585, 693-699 (2011).
25. N. Vickaryous, G. Polanco-Echeverry, S. Morrow, N. Suraweera, H. Thomas, I. Tomlinson, A. Silver, Smooth-muscle myosin mutations in hereditary non-polyposis colorectal cancer syndrome. Br. J. Cancer 99, 1726-1728 (2008).
26. B. Koos, S. Bender, H. Witt, S. Mertsch, J. Felsberg, R. Beschorner, A. Korshunov, B. Riesmeier, S. Pfister, W. Paulus, M. Hasselblatt, The transcription factor Evi-1 is overexpressed, promotes proliferation, and is prognostically unfavorable in infratentorial ependymomas. Clin. Cancer Res. 17, 3631-3637 (2011).
27. M. J. van den Bent, A. A. Brandes, R. Rampling, M. C. Kouwenhoven, J. M. Kros, A. F. Carpentier, P. M. Clement, M. Frenay, M. Campone, J. F. Baurain, J. P. Armand, M. J. Taphoorn, A. Tosoni, H. Kletzl, B. Klughammer, D. Lacombe, T. Gorlia, Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC Brain Tumor Group Study 26034. J. Clin. Oncol. 27, 1268-1274 (2009).
28. D. N. Louis, Molecular pathology of malignant gliomas. Annu. Rev. Pathol. 1, 97-117 (2006).
29. T. A. Libermann, H. R. Nusbaum, N. Razon, R. Kris, I. Lax, H. Soreq, N. Whittle, M. D. Waterfield, A. Ullrich, J. Schlessinger, Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin. Nature 313, 144-147 (1985). (Pubitemid 15192341)
30. M. Snuderl, L. Fazlollahi, L. P. Le, M. Nitta, B. H. Zhelyazkova, C. J. Davidson, S. Akhavanfard, D. P. Cahill, K. D. Aldape, R. A. Betensky, D. N. Louis, A. J. Iafrate, Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma. Cancer Cell 20, 810-817 (2011).
31. Q. W. Fan, C. K. Cheng, W. C. Gustafson, E. Charron, P. Zipper, R. A. Wong, J. Chen, J. Lau, C. Knobbe-Thomsen, M. Weller, N. Jura, G. Reifenberger, K. M. Shokat, W. A. Weiss, EGFR phosphorylates tumor-derived EGFRvIII driving STAT3/5 and progression in glioblastoma. Cancer Cell 24, 438-449 (2013).
32. M. Nagane, A. Levitzki, A. Gazit, W. K. Cavenee, H. J. Huang, Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-XL and caspase-3-like proteases. Proc. Natl. Acad. Sci. U. S. A. 95, 5724-5729 (1998).
33. H. S. Phillips, S. Kharbanda, R. Chen, W. F. Forrest, R. H. Soriano, T. D. Wu, A. Misra, J. M. Nigro, H. Colman, L. Soroceanu, P. M. Williams, Z. Modrusan, B. G. Feuerstein, K. Aldape, Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9, 157-173 (2006). (Pubitemid 43357943)
34. M. D. Inda, R. Bonavia, J. Seoane, Glioblastoma multiforme: A look inside its heterogeneous nature. Cancers 6, 226-239 (2014).
35. A. Sottoriva, I. Spiteri, S. G. Piccirillo, A. Touloumis, V. P. Collins, J. C. Marioni, C. Curtis, C. Watts, S. Tavaré, Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proc. Natl. Acad. Sci. U. S. A. 110, 4009-4014 (2013).
36. H. Chen, A. S. Shah, R. E. Girgis, S. A. Grossman, Transmission of glioblastoma multiforme after bilateral lung transplantation. J. Clin. Oncol. 26, 3284-3285 (2008).
37. M. A. Fatt, K. M. Horton, E. K. Fishman, Transmission of metastatic glioblastoma multiforme from donor to lung transplant recipient. J. Comput. Assist. Tomogr. 32, 407-409 (2008).
38. P. Zhao, A. Strohl, C. Gonzalez, T. Fishbein, S. Rosen-Bronson, B. Kallakury, M. Ozdemirli, Donor transmission of pineoblastoma in a two-yr-old male recipient of a multivisceral transplant: A case report. Pediatr. Transplant. 16, E110-E114 (2012).
39. M. Y. Armanios, S. A. Grossman, S. C. Yang, B. White, A. Perry, P. C. Burger, J. B. Orens, Transmission of glioblastoma multiforme following bilateral lung transplantation from an affected donor: Case study and review of the literature. Neuro. Oncol. 6, 259-263 (2004). (Pubitemid 39136509)
40. P. J. Healey, C. L. Davis, Transmission of tumours by transplantation. Lancet 352, 2-3 (1998). (Pubitemid 28306551)
41. I. F. Parney, Basic concepts in glioma immunology. Adv. Exp. Med. Biol. 746, 42-52 (2012).
42. J. C. Fischer, D. Niederacher, S. A. Topp, E. Honisch, S. Schumacher, N. Schmitz, L. Zacarias Föhrding, C. Vay, I. Hoffmann, N. S. Kasprowicz, P. G. Hepp, S. Mohrmann, U. Nitz, A. Stresemann, T. Krahn, T. Henze, E. Griebsch, K. Raba, J. M. Rox, F. Wenzel, C. Sproll, W. Janni, T. Fehm, C. A. Klein, W. T. Knoefel, N. H. Stoecklein, Diagnostic leukapheresis enables reliable detection of circulating tumor cells of nonmetastatic cancer patients. Proc. Natl. Acad. Sci. U. S. A. 110, 16580-16585 (2013).
43. F. Chen, W. Karolak, M. Cypel, S. Keshavjee, A. Pierre, Intermediate-term outcome in lung transplantation from a donor with glioblastoma multiforme. J. Heart Lung Transplant. 28, 1116-1118 (2009).
44. M. A. Nalesnik, E. S. Woodle, J. M. Dimaio, B. Vasudev, L. W. Teperman, S. Covington, S. Taranto, J. P. Gockerman, R. Shapiro, V. Sharma, L. J. Swinnen, A. Yoshida, M. G. Ison, Donor-transmitted malignancies in organ transplantation: Assessment of clinical risk. Am. J. Transplant. 11, 1140-1147 (2011).
45. H. M. Kauffman, W. S. Cherikh, M. A. McBride, Y. Cheng, D. W. Hanto, Deceased donors with a past history of malignancy: An organ procurement and transplantation network/united network for organ sharing update. Transplantation 84, 272-274 (2007). (Pubitemid 47205764)
46. S. Braun, K. Pantel, Immunocytochemical detection and characterization of individual micrometastatic tumor cells. Methods Mol. Med. 57, 67-73 (2001).
47. A. Schulte, H. S. Günther, T. Martens, S. Zapf, S. Riethdorf, C. Wülfing, M. Stoupiec, M. Westphal, K. Lamszus, Glioblastoma stem-like cell lines with either maintenance or loss of high-level EGFR amplification, generated via modulation of ligand concentration. Clin. Cancer Res. 18, 1901-1913 (2012).
48. R. R. Mathiesen, R. Fjelldal, K. Liestøl, E. U. Due, J. B. Geigl, S. Riethdorf, E. Borgen, I. H. Rye, I. J. Schneider, A. C. Obenauf, O. Mauermann, G. Nilsen, O. Christian Lingjaerde, A. L. Børresen-Dale, K. Pantel, M. R. Speicher, B. Naume, L. O. Baumbusch, High-resolution analyses of copy number changes in disseminated tumor cells of patients with breast cancer. Int. J. Cancer 131, E405-E415 (2012).
49. C. Gasch, T. Bauernhofer, M. Pichler, S. Langer-Freitag, M. Reeh, A. M. Seifert, O. Mauermann, J. R. Izbicki, K. Pantel, S. Riethdorf, Heterogeneity of epidermal growth factor receptor status and mutations of KRAS/PIK3CA in circulating tumor cells of patients with colorectal cancer. Clin. Chem. 59, 252-260 (2013).
50. E. H. van Beers, S. A. Joosse, M. J. Ligtenberg, R. Fles, F. B. Hogervorst, S. Verhoef, P. M. Nederlof, A multiplex PCR predictor for aCGH success of FFPE samples. Br. J. Cancer 94, 333-337 (2006). (Pubitemid 43151556)
51. S. Langer, J. B. Geigl, R. Gangnus, M. R. Speicher, Sequential application of interphase-FISH and CGH to single cells. Lab. Invest. 85, 582-592 (2005). (Pubitemid 40523948)
52. J. B. Geigl, A. C. Obenauf, J. Waldispuehl-Geigl, E. M. Hoffmann, M. Auer, M. Hörmann, M. Fischer, Z. Trajanoski, M. A. Schenk, L. O. Baumbusch, M. R. Speicher, Identification of small gains and losses in single cells after whole genome amplification on tiling oligo arrays. Nucleic Acids Res. 37, e105 (2009).
53. H. Li, R. Durbin, Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754-1760 (2009).
54. H. Li, B. Handsaker, A. Wysoker, T. Fennell, J. Ruan, N. Homer, G. Marth, G. Abecasis, R. Durbin; 1000 Genome Project Data Processing Subgroup, The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078-2079 (2009).
55. S. Rozen, H. Skaletsky, Primer3 on the WWW for general users and for biologist programmers. Methods Mol. Biol. 132, 365-386 (2000).
56. D. J. Giard, S. A. Aaronson, G. J. Todaro, P. Arnstein, J. H. Kersey, H. Dosik, W. P. Parks, In vitro cultivation of human tumors: Establishment of cell lines derived from a series of solid tumors. J. Natl. Cancer Inst. 51, 1417-1423 (1973).
57. M. Westphal, M. Hänsel, W. Hamel, R. Kunzmann, F. Hölzel, Karyotype analyses of 20 human glioma cell lines. Acta Neurochir. 126, 17-26 (1994). (Pubitemid 24027537)
58. A. Schulte, H. S. Günther, H. S. Phillips, D. Kemming, T. Martens, S. Kharbanda, R. H. Soriano, Z. Modrusan, S. Zapf, M. Westphal, K. Lamszus, A distinct subset of glioma cell lines with stem cell-like properties reflects the transcriptional phenotype of glioblastomas and overexpresses CXCR4 as therapeutic target. Glia 59, 590-602 (2011).
59. S. Werner, S. Frey, S. Riethdorf, C. Schulze, M. Alawi, L. Kling, V. Vafaizadeh, G. Sauter, L. Terracciano, U. Schumacher, K. Pantel, V. Assmann, Dual roles of the transcription factor grainyhead-like 2 (GRHL2) in breast cancer. J. Biol. Chem. 288, 22993-23008 (2013).